| Expression pattern: |
UP |
| Associated gene: |
IFNB1 |
| Associated microRNA: |
hsa-miR-145-5p |
| Biological function: |
May participate in COVID-19 immunopathogenesis and innate immune response regulation; may function as a biomarker and therapeutic target in COVID-19 patients. |
| Molecular mechanism: |
ceRNA mechanism in which hsa_circ_0009910 may sponge hsa-miR-145-5p and regulate IFNB1-associated immune pathways. |
| Biological pathway or process: |
ceRNA regulation (other); immune regulation (promotes); inflammation (promotes); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
hsa_circ_0009910 might be a useful biomarker to distinguish COVID-19 patients from healthy controls and may be considered a therapeutic target. |
| Description: |
hsa_circ_0009910 was up-regulated in PBMCs from symptomatic and nonsymptomatic COVID-19 patients compared with negative controls. The study suggests that hsa_circ_0009910 may act through a hsa-miR-145-5p/IFNB1 ceRNA axis involved in COVID-19 immune responses and may have biomarker and therapeutic-target potential. |
| Confidence score: |
0.459 |